Clinical Liver Disease

  • Author: Vários
  • Narrator: Vários
  • Publisher: Podcast
  • Duration: 111:15:50
  • More information

Informações:

Synopsis

Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.

Episodes

  •  16-1: The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection

    16-1: The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection

    25/10/2020 Duration: 09min

    Audible Article by Camilla S. Graham

  •  16-1: Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics

    16-1: Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics

    25/10/2020 Duration: 09min

    Audible Article by Lynn E. Taylor

  •  16-1: State of the Hepatitis C Virus Care Cascade

    16-1: State of the Hepatitis C Virus Care Cascade

    25/10/2020 Duration: 09min

    Audible Article by David L. Thomas

  •  16-1: Management of Hepatitis C-Infected Patients After Sustained Virological Response

    16-1: Management of Hepatitis C-Infected Patients After Sustained Virological Response

    25/10/2020 Duration: 09min

    Audible Article by Brian Pearlman

  •  16-1: Management of Direct-Acting Antiviral Failures

    16-1: Management of Direct-Acting Antiviral Failures

    25/10/2020 Duration: 09min

    Audible Article by Maryam Alimirah, Omar Sadiq, and Stuart C. Gordon

  •  16-1: Management of Hepatitis C-Infected Patients After Sustained Virological Response

    16-1: Management of Hepatitis C-Infected Patients After Sustained Virological Response

    25/10/2020 Duration: 09min

    Audible Article by Brian Pearlman

  •  16-1: The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection

    16-1: The Current Status of US and Global Access to Direct-Acting Antiviral Regimens for Hepatitis C Virus Infection

    25/10/2020 Duration: 09min

    AAudible Article by Camilla S. Graham

  •  16-1: Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics

    16-1: Colocalization in Hepatitis C Virus Infection Care: The Role of Opioid Agonist Therapy Clinics

    25/10/2020 Duration: 09min

    Audible Article by Lynn E. Taylor

  •  16-1: State of the Hepatitis C Virus Care Cascade

    16-1: State of the Hepatitis C Virus Care Cascade

    25/10/2020 Duration: 09min

    Audible Article by David L. Thomas

  •  16-1: Novel Models of Hepatitis C Virus Care Delivery: Telemedicine, Project ECHO, and Integrative Care

    16-1: Novel Models of Hepatitis C Virus Care Delivery: Telemedicine, Project ECHO, and Integrative Care

    25/10/2020 Duration: 09min

    Audible Article by Sanjeev Arora and Karla Thornton

  •  16-1: HCV Elimination in a Health Network Serving Indigenous Communities in Northern California

    16-1: HCV Elimination in a Health Network Serving Indigenous Communities in Northern California

    25/10/2020 Duration: 09min

    Audible Article by Kathleen Cassel and Gregory Carlson

  •  16-1: Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis

    16-1: Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis

    25/10/2020 Duration: 09min

    Audible Article by Laila Fozouni and Jennifer C. Lai

  •  16-S1: Hemochromatosis: Ancient to the Future

    16-S1: Hemochromatosis: Ancient to the Future

    25/10/2020 Duration: 09min

    Interview with Paul C. Adams

  •  16-S1: Can We Add the History of the Nonoperative Therapy of Varices to Other Success Chapters to Modern Medicine?

    16-S1: Can We Add the History of the Nonoperative Therapy of Varices to Other Success Chapters to Modern Medicine?

    25/10/2020 Duration: 09min

    Interview with Mina Niazi

  •  16-S1: A History of Coagulopathy in Liver Disease: Legends and Myths

    16-S1: A History of Coagulopathy in Liver Disease: Legends and Myths

    25/10/2020 Duration: 09min

    Interview with Patrick Northup

  •  16-S1: Acetaminophen Toxicity: A History of Serendipity and Unintended Consequences

    16-S1: Acetaminophen Toxicity: A History of Serendipity and Unintended Consequences

    25/10/2020 Duration: 09min

    Interview with Wiliam M. Lee

  •  16-S1: We Are All Africans: A Highly Personal Migratory View of the History of Hepatitis B

    16-S1: We Are All Africans: A Highly Personal Migratory View of the History of Hepatitis B

    25/10/2020 Duration: 09min

    Interview with Robert G. Gish

  •  16-S1: The History of Hepatitis A

    16-S1: The History of Hepatitis A

    25/10/2020 Duration: 09min

    Interview with Daniel Shouval

  •  16-S1: Hemochromatosis: Ancient to the Future

    16-S1: Hemochromatosis: Ancient to the Future

    25/10/2020 Duration: 09min

    Audible Article by Paul C. Adams

  •  16-S1: Can We Add the History of the Nonoperative Therapy of Varices to Other Success Chapters to Modern Medicine?

    16-S1: Can We Add the History of the Nonoperative Therapy of Varices to Other Success Chapters to Modern Medicine?

    25/10/2020 Duration: 09min

    Audible Article by Mina Niazi and Juan G. Abraldes

page 1 from 34